Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?
Fukagawa
Masafumi
M
Division of Nephrology and Dialysis Center, Kobe University School of Medicine, Kobe, Japan. fukagawa@med.kobe-u.ac.jp
D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood; D000069449:Cinacalcet; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D044169:Receptors, Calcium-Sensing / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D014807:Vitamin D / Q000627:therapeutic use
D009281:Naphthalenes; D010281:Parathyroid Hormone; D044169:Receptors, Calcium-Sensing; D014807:Vitamin D; D010758:Phosphorus; D002118:Calcium; D000069449:Cinacalcet